Improving diverse enrollment in cancer clinical trials
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
This study is working to make sure that more Black and Latino people can join cancer clinical trials, so everyone can benefit from new treatments and care advancements.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ecog-Acrin Medical Research Foundation NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10909090 on NIH RePORTER |
What this research studies
This research aims to address the lack of diversity in cancer clinical trials, particularly among Black and Latino populations, which contributes to health disparities. It will implement multilevel interventions to enhance the referral and enrollment of these underrepresented groups in National Cancer Institute-supported clinical trials. By engaging community providers and utilizing patient navigation and research literacy tools, the project seeks to create a more equitable representation in clinical research. The ultimate goal is to ensure that all populations can benefit from advancements in cancer care.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black and Latino patients who are currently facing barriers to participating in cancer clinical trials.
Not a fit: Patients who are not part of racial or ethnic minority groups may not directly benefit from the specific focus of this research.
Why it matters
Potential benefit: If successful, this research could lead to more equitable access to cutting-edge cancer treatments for diverse populations.
How similar studies have performed: Previous initiatives aimed at increasing diversity in clinical trials have shown promise, indicating that this approach could be effective.
Where this research is happening
Philadelphia, United States
- Ecog-Acrin Medical Research Foundation — Philadelphia, United States (Active)
Researchers
- Principal investigator: Simon, Melissa a. — Ecog-Acrin Medical Research Foundation
- Study coordinator: Simon, Melissa a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.